TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models,Emerging Microbes & Infections

当前位置： X-MOL 学术 › Emerg. Microbes Infect. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models
Emerging Microbes & Infections ( IF 8.4 ) Pub Date : 2024-08-08 , DOI: 10.1080/22221751.2024.2387448
Yang Shi _{1,

2} , Zihan Wang _{1,

2} , Jingjing Xu _{1,

2} , Wenxia Niu ₃ , Yubin Wu _{1,

2} , Huiyu Guo _{1,

2} , Jinmiao Shi _{1,

2} , Zonglin Li _{1,

2} , Baorong Fu _{1,

2} , Yunda Hong _{1,

2} , Zikang Wang _{1,

2} , Wenjie Guo _{1,

2} , Dabing Chen _{1,

2} , Xingling Li _{1,

2} , Qian Li _{1,

2} , Shaojuan Wang _{1,

2} , Jiahua Gao _{1,

2} , Aling Sun ₃ , Yaosheng Xiao ₃ , Jiali Cao _{1,

2,

4} , Lijuan Fu ₃ , Yangtao Wu _{1,

2} , Tianying Zhang _{1,

2} , Ningshao Xia ₁ , Quan Yuan _{1,

2}

Affiliation

Therapeutics for eradicating hepatitis B virus (HBV) infection are still limited and current nucleos(t)ide analogs (NAs) and interferon are effective in controlling viral replication and improving ...

中文翻译：